Gustavo Saraiva Dos Anjos | Global Market Access Director For Biologics

Gustavo Saraiva Dos Anjos, Global Market Access Director For Biologics, GlaxoSmithKline


Day 1- Thu 24th September 2020 @ 14:10

Chair’s remarks

Day 2- Fri 25th September 2020 @ 09:40

Achieving greater stakeholder engagement and innovation to improve outcomes

  • What key initiatives are helping to improve cooperation among payers, patients and manufacturers?
  • What innovation is taking place in contracting?
  • What suggestions would you offer to streamline contracting arrangements and improve patient & payer outcomes?
last published: 06/Jul/20 12:55 GMT

back to speakers

Contact us

To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052

To speak:
Chris Shanks
+44 (0)207 092 1151